Kontigo Care: Additional clinical study for mobile phone-based drug monitoring - Redeye

Redeye is excited to hear that Kontigo Care has signed an agreement with Region Uppsala to conduct a clinical study for mobile phone-based drug monitoring starting in March 2023. This second study is another critical step towards launching a new unique product line, mobile-based drug monitoring.

Länk till analysen i sin helhet: https://www.redeye.se/research/888510/kontigo-care-additional-clinical-study-for-mobile-phone-based-drug-monitoring?utm_source=finwire&utm_medium=RSS